Research Institute for Science & Technology, Tokyo University of Science

  History and Background of This Division

This division has a root in the DDS Research Division established in the Research Institutes for Science and Technology, Tokyo University of Science in 2003. In “Fusion of Regenerative Medicine with DDS Division” started from 2015, researchers headed by Professor Kimiko Makino have conducted collaborative researches focusing on regenerative medicine and the development of DDS for intractable diseases. To continue these activities, a predecessor round-table conference on Superior Cells and DDS Development for Regenerative Medicine was founded on 2020, which has been re-established as a division in April 2021.

  Research Purposes and Goals of This Division

Under the overall goal of accelerating regenerative medicine, this division is focusing on (1) the development of “superior cells” by functionalizing the cells administered to patients for therapeutic purposes, and (2) the development of DDS that can precisely manipulate the in vivo distribution of cells and other functional molecules. The research purposes also include the development of therapeutic modalities against respiratory, brain, immune, cancer, and bone diseases.